A single center audit comparing the switch from darbepoetin alfa to an epoetin alfa biosimilar and backwards in hemodialysis patients

被引：0
|
作者：
Jungbluth, H.
Haegele, B.
机构：
来源：
SWISS MEDICAL WEEKLY | 2010年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：21S / 22S
页数：2
相关论文
共 50 条
  • [1] An audit comparing epoetin alfa/beta to darbepoetin alfa in hemodialysis patients
    Glueck, Zeev
    Zuercher, Alfred
    Von Schack, Bettina
    Zysset, Thomas
    Saldutto, Biagio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 153 - 154
  • [2] An audit comparing subcutaneous epoetin alfa to intravenous darbepoetin alfa in chronic hemodialysis patients
    Summers, S
    Winnett, G
    Matijevic, A
    Carmichael, D
    Almond, M
    DIALYSIS & TRANSPLANTATION, 2005, 34 (06) : 358 - +
  • [3] Comparative study of epoetin alfa and darbepoetin alfa in hemodialysis patients
    Valdueza, Julio
    Martinez, Noemi
    Martinez, M. Jose
    Montero, Monica
    Alvarez, Juliana
    Siquier, Pedro
    Inaraja, Maria T.
    Castro, Ines
    Pego, Jose M.
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 475 - 476
  • [4] Results of a switch from darbepoetin alfa to epoetin beta in a hemodialysis unit
    Biggar, Patrick
    Doemling, Renate
    Hennemann, Hans
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 170 - 170
  • [5] Switch from epoetin to darbepoetin alfa in hemodialysis: dose equivalence and hemoglobin stability
    Arrieta, Javier
    Moina, Inigo
    Molina, Jose
    Gallardo, Isabel
    Muniz, Maria Luisa
    Robledo, C. Armen
    Garcia, Oscar
    Vidaur, Fernando
    Muoz, Rosa Ines
    Iribar, Izaskun
    Aguirre, Roman
    Maza, Antonio
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2014, 7 : 353 - 359
  • [6] Clinical outcomes associated with conversion from epoetin alfa to darbepoetin alfa in hospitalized hemodialysis patients
    Sarac, Erdal
    Chikyarappa, Anand
    Sabol, Brian
    Gemmel, David
    Globe, Denise
    Barlev, Arie
    Audhya, Paul
    AMERICAN JOURNAL OF NEPHROLOGY, 2006, 26 (06) : 571 - 578
  • [7] Therapeutic Efficacy of a Biosimilar Epoetin Alfa in Hemodialysis Patients
    Harzallah, Amel
    Zouaghi, Karim
    Dridi, Afef
    Boubaker, Karima
    Beji, Soumaya
    Ayari, Mohamed
    El Younsi, Fethi
    Ben Moussa, Fatma
    Kheder, Adel
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2015, 26 (01) : 78 - 82
  • [8] Resistance index to epoetin alfa and to darbepoetin alfa in chronic hemodialysis patients:: A cohort study
    Perez-Garcia, R.
    Benitez, P. Rodriguez
    Jofre, R.
    Lopez-Gomez, J. M.
    Villaverde, M. T.
    Blanco, A.
    Blanco, S.
    Sanchez, M.
    NEFROLOGIA, 2007, 27 (03): : 340 - 349
  • [9] Dose conversion from epoetin alfa to darbepoetin alfa for patients with chronic kidney disease receiving hemodialysis
    Barnett, AI
    Crémieux, PY
    PHARMACOTHERAPY, 2003, 23 (05): : 690 - 693
  • [10] Switch from rHuEPO to darbepoetin alfa in hemodialysis patients in a clinical setting
    Wiesholzer, Martin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 154 - 155
12345